Latest Prescription Drugs news

Tivozanib Bests Sorafenib in Metastatic Renal Cell Carcinoma

Among patients with metastatic renal cell carcinoma, progression-free survival was longer in those receiving tivozanib versus sorafenib as third- or fourth-line therapy, according to a study published online Dec. 3 in The Lancet Oncology.

Gabapentinoids, Opioids Combo Carries Risk for Breathing Problems

New warnings about the risk for dangerous breathing difficulties when gabapentinoids are used with opioids or by certain patients must now appear on product labels, the U.S. Food and Drug Administration announced Thursday.

Misuse of Nonopioid Medications Appears to Be on the Rise in U.S.

Misuse/abuse, use in suicide attempts, and hospital admissions associated with gabapentin and baclofen have significantly increased among U.S. adults since 2013, according to a study published online Dec. 1 in Clinical Toxicology.

SABCS: Anastrozole Tied to Lasting Reduction in Breast Cancer Risk

Anastrozole is associated with a long-term reduction in breast cancer risk, even after treatment, according to a study published online Dec. 12 in The Lancet to coincide with the annual San Antonio Breast Cancer Symposium, held from Dec. 10 to 14 in Texas.